EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes

Shinjiro Fukami, Jiro Akimoto, Kenta Nagai, Nobuyuki Nakajima, Norio Ichimasu, Ken Matsushima, Sho Onodera, Yuki Saito, Michihiro Kohno

Journal of Neuro-Oncology · 2026-04 · 177 (2)

DOI: 10.1007/s11060-026-05550-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 31.03.2026. Verfasst von Shinjiro Fukami und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-023, Japan. fukami@tokyo-med.ac.jp. Hauptthemen laut MEDLINE: Meningioma, Meningeal Neoplasms, Photochemotherapy, Porphyrins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Atypical and anaplastic (grade 2/3) meningiomas are associated with high recurrence rates and lack effective systemic therapies other than radiotherapy. Photodynamic therapy (PDT) using talaporfin sodium (TPS) generates selective cytotoxicity extending beyond resection margins and may improve local tumor control. Objective is to evaluate the feasibility, safety, and clinical outcomes of additional intraoperative PDT using TPS for grade 2/3 meningioma patients.

Methods

Nineteen patients with grade 2/3 meningiomas who underwent resection together with PDT at our institute between 2015 and 2025 were retrospectively analyzed. PDT was performed 22 to 26 h after intravenous TPS administration. Tumor location, pathology, Simpson resection grades, history of radiation therapy (RT), and outcomes were reviewed.

Results

Of the 19 patients, 18 had recurrent tumors, and 10 had prior RT. Tumor sites included skull base (8 patients), parasagittal sinus (6), convexity (2), falx (1), subcutaneous (1), and intraventricular (1). Histology revealed grade 2 (12 patients) and grade 3 (7), with Simpson I (3), II (6), III (2), and IV (8) resections. Median progression-free survival was 12.5 months, and median overall survival after PDT was 54.5 months. The prognosis was more favorable in RT- naïve patients than in those with a history of prior RT before PDT.

Conclusion

PDT combined with resection is a safe adjunctive strategy for grade 2/3 meningiomas. Our preliminary data suggest that its efficacy is limited in post-radiation recurrences, but it may delay disease progression when applied before RT. PDT should hence be considered as a therapeutic option for grade 2/3 meningiomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaMeningeal NeoplasmsPhotochemotherapyPorphyrinsPhotosensitizing AgentsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedFeasibility StudiesAdultFollow-Up StudiesTreatment OutcomeNeoplasm GradingNeoplasm Recurrence, LocalPrognosis

Stichwörter der Autor:innen

Grade 2/3 meningiomaPhotodynamic therapyRecurrenceSurgical resectionTalaporfin sodium

Substanzen

TalaporfinPorphyrinsPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-023, Japan. fukami@tokyo-med.ac.jp.
  • Department of Neurosurgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-023, Japan.
  • Department of Neurosurgery, Kohsei Chuo General Hospital, Tokyo, Japan.

Zitieren

APA

Fukami, S., Akimoto, J., Nagai, K., Nakajima, N., Ichimasu, N., Matsushima, K., Onodera, S., Saito, Y., & Kohno, M. (2026). Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes. Journal of Neuro-Oncology, 177(2). https://doi.org/10.1007/s11060-026-05550-2

Vancouver

Fukami S, Akimoto J, Nagai K, Nakajima N, Ichimasu N, Matsushima K, et al. Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes. Journal of Neuro-Oncology. 2026;177(2). doi:10.1007/s11060-026-05550-2

BibTeX
@article{Fukami2026,
  author = {Fukami, Shinjiro and Akimoto, Jiro and Nagai, Kenta and Nakajima, Nobuyuki and Ichimasu, Norio and Matsushima, Ken and Onodera, Sho and Saito, Yuki and Kohno, Michihiro},
  title = {Photodynamic therapy using talaporfin sodium for grade 2/3 meningiomas: a preliminary study of safety, feasibility, and clinical outcomes},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  volume = {177},
  number = {2},
  doi = {10.1007/s11060-026-05550-2}
}
Kostenlos starten →